¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"minimum target dose"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
target cell
Ç¥Àû¼¼Æ÷
target cell anemia
Ç¥Àû¼¼Æ÷ºóÇ÷
target configuration
°ú³á¸ð¾ç, Ç¥Àû¸ð¾ç
target gland
Ç¥Àû»ù, Ç¥Àû¼±
target lesion
Ç¥Àûº´ÅÍ
target organ
Ç¥ÀûÀå±â
target population
Ç¥ÀûÁý´Ü
target sign
Ç¥Àû¡ÈÄ
target skin distance
Ç¥ÀûÇǺΰŸ®
acceptable daily dose
ÀÏÀÏÇã¿ë·®
average dose
1. Æò±Õ¿ë·® 2. Æò±Õ¼±·®
air dose
°ø±â¼±·®
absorbed dose
Èí¼ö¼±·®
absorbed dose conversion factor
Èí¼ö¼±·®º¯È¯°è¼ö
absorbed dose rate
Èí¼ö¼±·®·ü
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
1
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
dose-response relationship
¿ë·®¹ÝÀÀ°ü°è
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
target configuration
°ú³á¸ð¾ç, Ç¥Àû¸ð¾ç
source-target distance
¼±¿øÇ¥Àû°£°Å¸®
target skin distance
Ç¥ÀûÇǺΰŸ®
target gland
Ç¥Àû»ù
target lesion
Ç¥Àûº´ÅÍ
target organ
Ç¥ÀûÀå±â
planning target volume
°èȹǥÀûºÎÇÇ
target population
Ç¥ÀûÁý´Ü
target skin distance radiation
Ç¥ÀûÇǺΰŸ®¹æ»ç¼±
target sign
Ç¥Àû¡ÈÄ
target
Ç¥Àû
absorbed dose
Èí¼ö¼±·®
absorbed dose rate
Èí¼ö¼±·®·ü
absorbed dose conversion factor
Èí¼ö¼±·®º¯È¯°è¼ö
acceptable daily dose
ÀÏÀÏÇã¿ë·®
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
LD50 (50% lethal dose)
50% Ä¡»ç·®
LD= lethal dose
Ä¡»ç·®.
MTD=> maximum toderance dose
ÃÖ´ë³»¿ë·®.
MTD=£¾maximum tolerance dose
ÃÖ´ë³»¿ë·®.
MTD=ÊÝmaximum toderance dose
ÃÖ´ë³»¿ë·®.
STD= standard test dose
Ç¥ÁؽÃÇè·®.
absorbed dose
Èí¼ö·®.¹æ»ç¼±Èí¼ö¼±·®(ýåâ¥àÊåÖ).
absorbed dose
Èí¼ö¼±·®
absorbed dose conversion factor
Èí¼ö¼±·®º¯È¯°è¼ö
absorbed dose rate
Èí¼ö¼±·®À²
acceptable daily dose : ADD
ÀÏÀÏÇã¿ë·®(ìéìíúÉé»Õá).
acceptable dose
¿ëÀμ±·®, ¼ö¿ë¼±·®, Çã¿ë¼±·®
adult dosage =a. dose
¼ºÀη®, ¼ºÀο뷮.
arbitrary dose
ÀÓÀǿ뷮(ìòëòéÄåÖ).
fractional dose
ºÐÇÒ·®.
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
minimum toxic dose
ÃÖ¼ÒÁßµ¶·®(̧ËÛÌ¡ËÄËâ).
cumulative dose ; cumulate dose
´©Àû¿ë·®.
cumulative dose ; cumulate dose
ÃàÀû(¿ë)·®, ´©Àû(¿ë)·®, ´©ÀûÁ¶»ç(¿ë)·® , [¿¹¹æ] ÁýÀû¼±·®.
cumulative dose ; cumulate dose
ÃàÀû(¿ë)·®, ´©Àû(¿ë)·®, ´©ÀûÁ¶»ç(¿ë)·® .[¿¹¹æ]ÁýÀû¼±·®.
dose rate ; dosage rate ; dose per unit time
¹æ»ç ÀÓº´,ÇÙÀÇ,¾à¸®¼±·®·ü, ¿ë·®.
optimal dose ; optimum dose
ÃÖÀû·®, ÀûÁ¤·®(îêïáåÖ).
optimal dose ; optimum dose
¹æ»ç [¾à¸®,ÇØºÎ,¿¹¹æ]ÃÖÀû·®, ÀûÁ¤·®(ËøËøËâ).
optimal dose ; optimum dose
ÃÖÀû·®, ÀûÁ¤·®(îêïáåÖ).
accommodative target
Á¶ÀýÀ¯¹ß½ÃÇ¥
cell, target
Ç¥Àû¼¼Æ÷
clinical target volume, CTV
ÀÓ»óÇ¥ÀûüÀû
codocyte= target cell
Ç¥Àû¼¼Æ÷
fusional target
À¶ÇÕÇ¥Áö
leptocytes = target cell
Ç¥Àû»óÀûÇ÷±¸= Ç¥Àû¼¼Æ÷
planning target volume
°èȹ¿ë Ç¥ÀûºÎÇÇ
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½